BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26049342)

  • 21. Renal denervation for resistant hypertension treatment: a novel team approach.
    Fajadet J
    EuroIntervention; 2012 Oct; 8(6):655-7. PubMed ID: 23086782
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal denervation: one step backwards, three steps forward.
    Schlaich MP; Bakris GL
    Nat Rev Nephrol; 2018 Oct; 14(10):602-604. PubMed ID: 29980772
    [No Abstract]   [Full Text] [Related]  

  • 23. [Renal denervation to control hypertension - effectiveness difficult to assess].
    Markun S
    Praxis (Bern 1994); 2014 Apr; 103(8):469-70. PubMed ID: 24713384
    [No Abstract]   [Full Text] [Related]  

  • 24. [Renal denervation in hypertension: when? For whom? And for whom not?].
    Rump LC
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2495-7. PubMed ID: 23168982
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal denervation: unde venis et quo vadis?
    Nähle CP; Düsing R; Schild H
    Rofo; 2015 Apr; 187(4):237-47. PubMed ID: 25629384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The "resistant hypertension team": focus on a multidisciplinary approach to hypertension.
    Potthoff SA; Rump LC; Vonend O
    EuroIntervention; 2013 May; 9 Suppl R():R48-53. PubMed ID: 23732155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Charting new frontiers in interventional medicine.
    Fajadet J
    EuroIntervention; 2013 May; 9 Suppl R():R10-1. PubMed ID: 23732138
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives.
    Prochnau D; Figulla HR; Surber R
    Expert Rev Med Devices; 2013 Mar; 10(2):247-56. PubMed ID: 23480093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal denervation as therapy for hypertension: potentials and unanswered questions.
    Vink EE; Bots ML; Blankestijn PJ
    Eur J Prev Cardiol; 2013 Dec; 20(6):980-91. PubMed ID: 23610453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistant hypertension: medical management and alternative therapies.
    Ghofrani H; Weaver FA; Nadim MK
    Cardiol Clin; 2015 Feb; 33(1):75-87. PubMed ID: 25439332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal denervation revised.
    van den Meiracker AH
    Neth J Med; 2014 Nov; 72(9):440-1. PubMed ID: 25431388
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal denervation for the treatment of hypertension: the Dutch consensus.
    Verloop WL; Agema WR; Allaart CP; Blankestijn PJ; Khan M; Meuwissen M; Muijs van de Moer WM; Rensing BJ; Spiering W; Voskuil M; Doevendans PA;
    Neth J Med; 2014 Nov; 72(9):449-54. PubMed ID: 25431389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of renal sympathetic denervation in a refractory arterial hypertension patient.
    Martínez-Esteban MD; Aranda-Lara P; Muñoz J; Toledo-Rojas R; Sola-Moyano E; Torres-Rueda Á; Hernández-Marrero D
    Nefrologia; 2012; 32(5):670-3. PubMed ID: 23013955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldosterone antagonists and renal denervation: friends or foes?
    Mahfoud F; Ruilope LM; Böhm M; Schmieder RE
    Hypertension; 2015 Feb; 65(2):280-2. PubMed ID: 25421977
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of renal denervation on insulin resistance.
    Hering D; Esler MD; Schlaich MP
    Expert Rev Cardiovasc Ther; 2012 Nov; 10(11):1381-6. PubMed ID: 23244359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obstructive sleep apnoea, resistant hypertension and renal denervation.
    Witkowski A; Kadziela J
    EuroIntervention; 2013 May; 9 Suppl R():R105-9. PubMed ID: 23732140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.
    Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.